birth control news from FierceBioResearcher
NewsRNAi used as nonhormonal contraceptive
A group of researchers at Brigham and Women's Hospital in Boston are focused on developing a new, nonhormonal contraceptive that uses RNAi technology to silence the ZP3 gene, which is required to Read more...
| Press ReleasesPRESS RELEASE: Watson Files FDA Application for Generic YAZ(R) Watson Files FDA Application for Generic YAZ(R) - Paragraph IV Patent Challenge Underway - CORONA, Calif., Nov. 7 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical Read more... |
Get more birth control coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets